CDKN2A and sarcomatoid carcinoma: However, p16 overexpression was present in 12 (7.0%) patient samples diagnosed with invasive OSSN (basaloid SCC, n = 2, 33.3% and CSCC, n = 10, 6.2%), while spindle cell carcinomas were negative.